Bibliographie (2546)
WHO recommends antibody treatment for COVID patients at high risk of hospital admission.
vendredi, 24 septembre 2021 12:44 Écrit par Zouhair SouissiWHO recommends antibody treatment for COVID patients at high risk of hospital admission – British Medical Journal Original article and infographic: A living WHO guideline on drugs for covid-19 – The BMJ
The post WHO recommends antibody treatment for COVID patients at high risk of hospital admission. appeared first on Links Medicus.
No, vaccinated people are not ‘just as likely’ to spread the Coronavirus as unvaccinated people.
vendredi, 24 septembre 2021 12:44 Écrit par Zouhair SouissiNo, Vaccinated People Are Not ‘Just as Likely’ to Spread the Coronavirus as Unvaccinated People – The Atlantic Commentary on Twitter “Vaccinated people are just as likely to spread the coronavirus.” This isn't true. But some people — even some very smart people — mistakenly believe this. Dr. @Craig_A_Spencer explains here why, in this really good piece from @TheAtlantic.https://t.co/9D1dngt3oG […]
The post No, vaccinated people are not ‘just as likely’ to spread the Coronavirus as unvaccinated people. appeared first on Links Medicus.
![[Preprint] PRINCIPLE RCT: Colchicine does not improve time to recovery in outpatients with Covid-19 at higher risk of complications.](/media/k2/items/cache/31b0007be0bca8231dbb415d837046c8_M.jpg)
[Preprint] PRINCIPLE RCT: Colchicine does not improve time to recovery in outpatients with Covid-19 at higher risk of complications.
vendredi, 24 septembre 2021 12:44 Écrit par Zouhair SouissiColchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial – medRxiv Related: COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required. Commentary on Twitter While COLCORONA trial found limited evidence that colchicine may […]
The post [Preprint] PRINCIPLE RCT: Colchicine does not improve time to recovery in outpatients with Covid-19 at higher risk of complications. appeared first on Links Medicus.
Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiImportance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care – Canadian Family Physician
The post Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care. appeared first on Links Medicus.
AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiSleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association News release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association
The post AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents. appeared first on Links Medicus.
ERS clinical practice guidelines on treatment of sarcoidosis.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiERS clinical practice guidelines on treatment of sarcoidosis – European Respiratory Journal
The post ERS clinical practice guidelines on treatment of sarcoidosis. appeared first on Links Medicus.
Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiClinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review – JAMA Network Open Commentary on Twitter Multisystem inflammatory syndrome has been reported in adults worldwide but may be hard to distinguish from acute biphasic #COVID19 and postacute sequelae of COVID-19. More research is needed to understand this emerging clinical entity. https://t.co/OnerzsZKVB — […]
The post Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults. appeared first on Links Medicus.
New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiNews release: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution – World Health Organization Original Guideline: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide Executive Summary: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen […]
The post New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution. appeared first on Links Medicus.
![[Preprint] Third dose of Sinopharm inactivated SARS-CoV-2 vaccine induces robust B and T cell responses.](/media/k2/items/cache/fc5d9d8578a06f6d4c69c78df34d3f3a_S.jpg)
[Preprint] Third dose of Sinopharm inactivated SARS-CoV-2 vaccine induces robust B and T cell responses.
jeudi, 23 septembre 2021 13:13 Écrit par Zouhair SouissiRobust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine – medRxiv Commentaries: Three doses of inactivated BBIBP-CorV SARS-CoV-2 vaccine induce robust B and T cell responses – News Medical Sinopharm’s COVID booster reverses antibody decline, enhances cell-based responses – study – Reuters
The post [Preprint] Third dose of Sinopharm inactivated SARS-CoV-2 vaccine induces robust B and T cell responses. appeared first on Links Medicus.
![[Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S.](/media/k2/items/cache/3d9d200e77520aff5d4ca2a5d7f84097_S.jpg)
[Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S.
mercredi, 22 septembre 2021 14:14 Écrit par Zouhair SouissiPress release: Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Commentaries: Johnson & Johnson says additional dose boosts Covid vaccine efficacy – STAT J&J booster 94% effective against severe COVID, company says – CIDRAP Two dose version of Johnson & Johnson […]
The post [Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S. appeared first on Links Medicus.
